Newsroom

Deep Learning Analysis of Serial CT Scans Correlates with Changes in how Patients Feel, Function and Survive in Fibrotic Interstitial Lung Disease
Science
18 November 2025

Deep Learning Analysis of Serial CT Scans Correlates with Changes in how Patients Feel, Function and Survive in Fibrotic Interstitial Lung Disease

2025 ERS Abstract
The Role of Quantitative CT in the Prognostication and Monitoring of Systemic Autoimmune Rheumatic Disease Related Interstitial Lung Disease
Science
2 November 2025

The Role of Quantitative CT in the Prognostication and Monitoring of Systemic Autoimmune Rheumatic Disease Related Interstitial Lung Disease

2025 BTS Abstract
Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery
News
27 October 2025

Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery

Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy
Science
21 October 2025

Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy

Combined Deep Learning Algorithms Demonstrate That Both Computed Tomography Phenotype and Anatomical Biomarkers Are Predictive of Prognosis and Progression in Idiopathic Pulmonary Fibrosis
Science
17 October 2025

Combined Deep Learning Algorithms Demonstrate That Both Computed Tomography Phenotype and Anatomical Biomarkers Are Predictive of Prognosis and Progression in Idiopathic Pulmonary Fibrosis

ATS Journals
Qureight has major presence at 2025 ERS Congress to highlight how advanced imaging biomarkers and AI are transforming interstitial lung disease research and drug development
News
27 September 2025

Qureight has major presence at 2025 ERS Congress to highlight how advanced imaging biomarkers and AI are transforming interstitial lung disease research and drug development

Appointment of Professor Tamera Corte to Qureight's Scientific Advisory Committee.
News
26 September 2025

Appointment of Professor Tamera Corte to Qureight's Scientific Advisory Committee.

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management
News
1 September 2025

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management

Qureight’s AI 3D imaging platform to support Calluna Pharma’s Phase 2 AURORA study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF)
News
27 August 2025

Qureight’s AI 3D imaging platform to support Calluna Pharma’s Phase 2 AURORA study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF)

Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
News
15 July 2025

Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion

Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
News
17 June 2025

Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

The Potential for Deep Learning Technology in Clinical Trials
Science
12 June 2025

The Potential for Deep Learning Technology in Clinical Trials

Journal of Clinical Studies
Deep Learning Quantitative Computed Tomography Analysis in the Australian Idiopathic Pulmonary Fibrosis Registry
Science
17 May 2025

Deep Learning Quantitative Computed Tomography Analysis in the Australian Idiopathic Pulmonary Fibrosis Registry

ATS Journals
Deep Learning-based Disease Severity Biomarkers on CT; Posthoc Analysis in a Phase 2a Placebo-controlled Study of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis
Science
16 May 2025

Deep Learning-based Disease Severity Biomarkers on CT; Posthoc Analysis in a Phase 2a Placebo-controlled Study of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis

ATS Journals
Monte Carlo External Control Arm Generation Utilising Real-world Patient Data and Deep Learning-based Quantitative CT Metrics Demonstrates Treatment Effect in the Atlas IPF Trial
Science
16 May 2025

Monte Carlo External Control Arm Generation Utilising Real-world Patient Data and Deep Learning-based Quantitative CT Metrics Demonstrates Treatment Effect in the Atlas IPF Trial

ATS Journals
Deep Learning-Based Short-Term Disease Progression Evaluation Supersedes Automated Baseline CT Phenotype in Predicting Outcomes in Idiopathic Pulmonary Fibrosis
Science
16 May 2025

Deep Learning-Based Short-Term Disease Progression Evaluation Supersedes Automated Baseline CT Phenotype in Predicting Outcomes in Idiopathic Pulmonary Fibrosis

ATS Journals
Deep Learning-Based Quantitative CT and CT Phenotype Classification Independently Predict Mortality in Idiopathic Pulmonary Fibrosis, a Prospective Observational Cohort Study
Science
16 May 2025

Deep Learning-Based Quantitative CT and CT Phenotype Classification Independently Predict Mortality in Idiopathic Pulmonary Fibrosis, a Prospective Observational Cohort Study

ATS Journals
Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis
Science
16 May 2025

Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis

ATS Journals